XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   267,744      
Beginning balance at Dec. 31, 2023 $ 701,304 $ 268 $ 2,539,892 $ 219 $ (1,839,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (251,497)       (251,497)
Other comprehensive income (loss) (742)     (742)  
Issuance of common stock in conjunction with equity plans (in shares)   4,747      
Issuance of common stock in conjunction with equity plans 6,891 $ 4 6,887    
Share-based compensation expense 36,744   36,744    
Ending balance (in shares) at Jun. 30, 2024   272,491      
Ending balance at Jun. 30, 2024 492,700 $ 272 2,583,523 (523) (2,090,572)
Beginning balance (in shares) at Mar. 31, 2024   272,280      
Beginning balance at Mar. 31, 2024 649,017 $ 272 2,566,304 (306) (1,917,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (173,319)       (173,319)
Other comprehensive income (loss) (217)     (217)  
Issuance of common stock in conjunction with equity plans (in shares)   211      
Share-based compensation expense 17,219   17,219    
Ending balance (in shares) at Jun. 30, 2024   272,491      
Ending balance at Jun. 30, 2024 $ 492,700 $ 272 2,583,523 (523) (2,090,572)
Beginning balance (in shares) at Dec. 31, 2024 294,418 294,418      
Beginning balance at Dec. 31, 2024 $ 506,594 $ 294 2,654,804 422 (2,148,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (468,005)       (468,005)
Other comprehensive income (loss) (155)     (155)  
Issuance of common stock in conjunction with equity plans (in shares)   5,932      
Issuance of common stock in conjunction with equity plans 1,959 $ 6 1,953    
Share-based compensation expense $ 21,096   21,096    
Ending balance (in shares) at Jun. 30, 2025 300,350 300,350      
Ending balance at Jun. 30, 2025 $ 61,489 $ 300 2,677,853 267 (2,616,931)
Beginning balance (in shares) at Mar. 31, 2025   300,041      
Beginning balance at Mar. 31, 2025 91,638 $ 300 2,665,958 381 (2,575,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (41,930)       (41,930)
Other comprehensive income (loss) (114)     (114)  
Issuance of common stock in conjunction with equity plans (in shares)   309      
Share-based compensation expense $ 11,895   11,895    
Ending balance (in shares) at Jun. 30, 2025 300,350 300,350      
Ending balance at Jun. 30, 2025 $ 61,489 $ 300 $ 2,677,853 $ 267 $ (2,616,931)